Cargando…
Inhibition of pancreatic cancer cell growth in vitro by the tyrphostin group of tyrosine kinase inhibitors.
Tyrphostins are a group of low molecular weight synthetic inhibitors of protein tyrosine kinases (PTK). The intracellular domains of the receptors for epidermal growth factor (EGF), transforming growth factor-alpha (TGF-alpha), insulin-like growth factor 1 (IGF-1) possess PTK activity. Since EGF, TG...
Autores principales: | Gillespie, J., Dye, J. F., Schachter, M., Guillou, P. J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1993
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968666/ https://www.ncbi.nlm.nih.gov/pubmed/8260363 |
Ejemplares similares
-
The inhibition of EGF-dependent proliferation of keratinocytes by tyrphostin tyrosine kinase blockers
Publicado: (1991) -
In vivo pharmacology and anti-tumour evaluation of the tyrphostin tyrosine kinase inhibitor RG13022.
por: McLeod, H. L., et al.
Publicado: (1996) -
Acute stimulation of glycolytic flux in cultured primary astrocytes by the tyrosine kinase inhibitor tyrphostin 23
por: Blumrich, Eva-Maria, et al.
Publicado: (2015) -
Tyrphostin AG17 inhibits adipocyte differentiation in vivo and in vitro
por: Camacho, Alberto, et al.
Publicado: (2018) -
Tyrphostin AG556 increases the activity of large conductance Ca(2+)‐activated K(+) channels by inhibiting epidermal growth factor receptor tyrosine kinase
por: Wang, Yan, et al.
Publicado: (2017)